PRESS RELEASES AND NEWS

12.04.2022

2022, Press Releases

SYNformulas at Vitafoods Europe: Future-oriented and on growth track

Clinically relevant therapy options with a focus on the intestinal microbiome: SYNformulas, one of the world's leading probiotics companies, will present its pioneering ...

read more ...

2022press-releases

21.10.2021

2021, Press Releases

CPhI worldwide: German probiotics company SYNformulas seeks partnerships to drive internationalization

SYNformulas, one of the leading probiotics companies in the field of treating intestinal complaints and allergies, is exhibiting for the first time at CPhI worldwide. From 9-11 November 2021 the company will present its groundbreaking ...

read more ...

2021press-releases

08.09.2021

2021, Press Releases

International probiotics company SYNformulas presents the scientifically researched potential of its products for the first time at Vitafoods Europe

SYNformulas, one of the leading probiotics companies in the field of treating gastrointestinal conditions and allergies with a focus on researching the human microbiome ...

read more ...

2021press-releases

31.08.2021

2021, Press Releases

Updated S3 guideline irritable bowel syndrome with new bacterial strain:

A big success for the patented bacterial strain of SYNformulas for the treatment of irritable bowel syndrome was achieved: The innovative bacterial strain B. bifidum MIMBb75, which is exclusively contained in Kijimea^® IBS, is now included in ...

read more ...

2021press-releases

04.06.2020

2020, Press Releases

Intelligent bacteria prove to be effective against the widespread irritable bowel syndrome (IBS)

One of the largest OTC studies regarding IBS³ published in the renowned medical journal The Lancet Gastroenterology & Hepatology produced sensational results. For the first time, leading ...

read more ...

2020press-releases